<DOC>
	<DOCNO>NCT01643889</DOCNO>
	<brief_summary>The purpose study assess effect single multiple dos domperidone QTc interval duration healthy adult volunteer domperidone dose 10 mg four time day ( q.i.d . ) 20 mg q.i.d .</brief_summary>
	<brief_title>A Study Evaluate Effects Domperidone Cardiac Repolarization Healthy Volunteers</brief_title>
	<detailed_description>This randomize ( study drug assign chance ) , placebo- positive-controlled , double-blind ( neither physician participant know treatment participant receives ) , single-dose multiple-dose , 4-way crossover ( method use switch participant one treatment arm another clinical trial ) study . A placebo control use evaluate effect domperidone QTc interval comparison placebo . QTc measure time heart electrical cycle . Placebo inactive substance compare drug test whether drug real effect clinical trial . Moxifloxacin , know prolong QTc interval , use positive control establish assay sensitivity . The participant randomly assign 1 4 treatment sequence group ( ADBC , BACD , CBDA , DCAB ) base computer-generated randomization schedule receive follow 4 treatment order specify randomization : Treatment A ( 10 mg domperidone ) ; Treatment B ( 20 mg domperidone ) ; Treatment C ( placebo ) ; Treatment D ( moxifloxacin ) . The study 3 phase : screening phase , double-blind treatment phase ( correspond 4 treatment period ) , assessment period . Each treatment period last 4 day separate washout period ( ie , period receive treatment ) 4 9 day . The participant confine clinical test facility approximately 5 day period . All treatment ( A , B , C D ) give orally water . The maximum study duration participant 74 day .</detailed_description>
	<mesh_term>Domperidone</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>If woman , must postmenopausal , surgically sterile , abstinent , , sexually active , practice effective method birth control If woman , must negative serum beta human chorionic gonadotropin ( hCG ) pregnancy test screening ; negative urine pregnancy test Day 1 treatment period Body mass index ( BMI ; weight [ kg ] /height2 [ ] 2 ) 18 30 kg/m2 ( inclusive ) , body weight less 50 kg Blood pressure 90 140 mmHg systolic , inclusive , high 90 mmHg diastolic An electrocardiogram ( ECG ) consistent normal cardiac conduction function History risk factor cardiac diseases Laboratorial test clinically significant abnormal value Clinically significant abnormal physical examination , vital sign electrocardiogram ( ECG ) screening Use prescription nonprescription medication ( include vitamin herbal supplement ) , except paracetamol within 14 day first dose study drug History current clinically significant medical illness , disease , condition investigator considers exclude participant could interfere interpretation study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Domperidone</keyword>
	<keyword>Cardiac Repolarization</keyword>
</DOC>